SCHEMBL13675833

SCHEMBL13675833

COOCc1sc(-c2cccc(OC)c2)nc1Nc1ccccc1C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
TDP1 Q9NUW8 2/20 0.42
NFKB1 P19838 1/20 0.42
RAB9A P51151 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
P2RY1 P47900 1/20 0.41
EGFR P00533 1/20 0.39
CRHR1 P34998 1/20 0.38
DGAT2 Q96PD7 1/20 0.38
LMNA P02545 2/20 0.36
SYK P43405 1/20 0.36
ULK1 O75385 1/20 0.36
PGR P06401 1/20 0.36
AR P10275 1/20 0.36
HDAC6 Q9UBN7 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13675586 0.84 MAPT (0.46) MAPTTDP1NFKB1RAB9ANFKB2
SCHEMBL13674671 0.80 SMN1; SMN2 (0.47) MAPTTDP1NFKB1RAB9ANFKB2
SCHEMBL3825251 0.80 RXFP1 (0.46) MAPTTDP1NFKB1RAB9ANFKB2
SCHEMBL3843773 0.80 RAB9A (0.45) MAPTTDP1NFKB1RAB9ANFKB2
SCHEMBL3831608 0.80 IKBKB (0.50) MAPTTDP1NFKB1RAB9ANFKB2
SCHEMBL13675685 0.73 MAPT (0.50) MAPTTDP1NFKB1RAB9ANFKB2
SCHEMBL13675585 0.71 PTGDR2 (0.47) MAPTNFKB1RAB9ANFKB2RELA
SCHEMBL3842362 0.69 GAA (0.47) MAPTRAB9ASMN1; SMN2LMNAMEN1
SCHEMBL22864101 0.68 MAPK14 (0.56) MAPTCRHR1ULK1MEN1KMT2A
SCHEMBL4557806 0.67 MEN1 (0.48) MAPTTDP1NFKB1RAB9ANFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270456-A1 Novel chemical compounds HASEGAWA MASAICHI 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270456-A1 Novel chemical compounds HIPK3, HIPK2, HIPK1 MAPT 1801/4885TDP1 1695/4885NFKB1 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.